nodes	percent_of_prediction	percent_of_DWPC	metapath
Amobarbital—Anaemia megaloblastic—Methotrexate—bone cancer	0.0669	0.0809	CcSEcCtD
Amobarbital—Liver injury—Cisplatin—bone cancer	0.0342	0.0413	CcSEcCtD
Amobarbital—Thiopental—CYP3A4—bone cancer	0.0314	0.408	CrCbGaD
Amobarbital—Pneumothorax—Epirubicin—bone cancer	0.0297	0.0359	CcSEcCtD
Amobarbital—Hepatocellular injury—Cisplatin—bone cancer	0.0287	0.0348	CcSEcCtD
Amobarbital—Body temperature increased—Carboplatin—bone cancer	0.0276	0.0334	CcSEcCtD
Amobarbital—Pneumothorax—Doxorubicin—bone cancer	0.0274	0.0332	CcSEcCtD
Amobarbital—Pentobarbital—CYP3A4—bone cancer	0.0261	0.338	CrCbGaD
Amobarbital—Hypoxia—Methotrexate—bone cancer	0.0248	0.03	CcSEcCtD
Amobarbital—Phenobarbital—CYP3A4—bone cancer	0.0195	0.253	CrCbGaD
Amobarbital—Apnoea—Methotrexate—bone cancer	0.0186	0.0225	CcSEcCtD
Amobarbital—Liver injury—Epirubicin—bone cancer	0.0175	0.0212	CcSEcCtD
Amobarbital—Liver injury—Doxorubicin—bone cancer	0.0162	0.0196	CcSEcCtD
Amobarbital—Thinking abnormal—Epirubicin—bone cancer	0.0161	0.0195	CcSEcCtD
Amobarbital—Respiratory failure—Methotrexate—bone cancer	0.0161	0.0194	CcSEcCtD
Amobarbital—Depressed level of consciousness—Methotrexate—bone cancer	0.0152	0.0184	CcSEcCtD
Amobarbital—Thinking abnormal—Doxorubicin—bone cancer	0.0149	0.018	CcSEcCtD
Amobarbital—Hepatocellular injury—Epirubicin—bone cancer	0.0148	0.0179	CcSEcCtD
Amobarbital—Bradycardia—Cisplatin—bone cancer	0.0147	0.0178	CcSEcCtD
Amobarbital—Injection site reaction—Epirubicin—bone cancer	0.0147	0.0177	CcSEcCtD
Amobarbital—Hepatocellular injury—Doxorubicin—bone cancer	0.0137	0.0165	CcSEcCtD
Amobarbital—Injection site reaction—Doxorubicin—bone cancer	0.0136	0.0164	CcSEcCtD
Amobarbital—Mental disability—Epirubicin—bone cancer	0.0128	0.0155	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Methotrexate—bone cancer	0.0121	0.0147	CcSEcCtD
Amobarbital—Mental disability—Doxorubicin—bone cancer	0.0119	0.0143	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Epirubicin—bone cancer	0.0114	0.0137	CcSEcCtD
Amobarbital—Ataxia—Methotrexate—bone cancer	0.0108	0.013	CcSEcCtD
Amobarbital—Anxiety—Cisplatin—bone cancer	0.0107	0.0129	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Doxorubicin—bone cancer	0.0105	0.0127	CcSEcCtD
Amobarbital—Ataxia—Epirubicin—bone cancer	0.0101	0.0122	CcSEcCtD
Amobarbital—Hypotension—Cisplatin—bone cancer	0.00958	0.0116	CcSEcCtD
Amobarbital—Ataxia—Doxorubicin—bone cancer	0.00932	0.0113	CcSEcCtD
Amobarbital—Feeling abnormal—Cisplatin—bone cancer	0.00845	0.0102	CcSEcCtD
Amobarbital—Body temperature increased—Cisplatin—bone cancer	0.00811	0.0098	CcSEcCtD
Amobarbital—Hypersensitivity—Cisplatin—bone cancer	0.00756	0.00914	CcSEcCtD
Amobarbital—Bradycardia—Epirubicin—bone cancer	0.00755	0.00913	CcSEcCtD
Amobarbital—Bradycardia—Doxorubicin—bone cancer	0.00698	0.00844	CcSEcCtD
Amobarbital—Vomiting—Cisplatin—bone cancer	0.00652	0.00789	CcSEcCtD
Amobarbital—Rash—Cisplatin—bone cancer	0.00647	0.00782	CcSEcCtD
Amobarbital—Dermatitis—Cisplatin—bone cancer	0.00646	0.00781	CcSEcCtD
Amobarbital—Tension—Epirubicin—bone cancer	0.00633	0.00766	CcSEcCtD
Amobarbital—Nervousness—Epirubicin—bone cancer	0.00627	0.00758	CcSEcCtD
Amobarbital—Nausea—Cisplatin—bone cancer	0.00609	0.00737	CcSEcCtD
Amobarbital—Agitation—Epirubicin—bone cancer	0.00593	0.00717	CcSEcCtD
Amobarbital—Tension—Doxorubicin—bone cancer	0.00586	0.00709	CcSEcCtD
Amobarbital—Nervousness—Doxorubicin—bone cancer	0.0058	0.00701	CcSEcCtD
Amobarbital—Syncope—Epirubicin—bone cancer	0.00579	0.007	CcSEcCtD
Amobarbital—Confusional state—Methotrexate—bone cancer	0.00567	0.00686	CcSEcCtD
Amobarbital—Loss of consciousness—Epirubicin—bone cancer	0.00567	0.00686	CcSEcCtD
Amobarbital—GRIA2—Hypothetical Network for Drug Addiction—GRM1—bone cancer	0.00556	0.0579	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—FEV—bone cancer	0.0055	0.0573	CbGpPWpGaD
Amobarbital—Agitation—Doxorubicin—bone cancer	0.00549	0.00664	CcSEcCtD
Amobarbital—Anxiety—Epirubicin—bone cancer	0.00547	0.00662	CcSEcCtD
Amobarbital—Syncope—Doxorubicin—bone cancer	0.00535	0.00647	CcSEcCtD
Amobarbital—Confusional state—Epirubicin—bone cancer	0.00531	0.00642	CcSEcCtD
Amobarbital—Hypotension—Methotrexate—bone cancer	0.00526	0.00636	CcSEcCtD
Amobarbital—Loss of consciousness—Doxorubicin—bone cancer	0.00525	0.00635	CcSEcCtD
Amobarbital—Shock—Epirubicin—bone cancer	0.00518	0.00627	CcSEcCtD
Amobarbital—Anxiety—Doxorubicin—bone cancer	0.00507	0.00613	CcSEcCtD
Amobarbital—Somnolence—Methotrexate—bone cancer	0.005	0.00605	CcSEcCtD
Amobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00496	0.0516	CbGpPWpGaD
Amobarbital—Hypotension—Epirubicin—bone cancer	0.00492	0.00595	CcSEcCtD
Amobarbital—Confusional state—Doxorubicin—bone cancer	0.00491	0.00594	CcSEcCtD
Amobarbital—Shock—Doxorubicin—bone cancer	0.00479	0.0058	CcSEcCtD
Amobarbital—Somnolence—Epirubicin—bone cancer	0.00468	0.00566	CcSEcCtD
Amobarbital—Feeling abnormal—Methotrexate—bone cancer	0.00464	0.00561	CcSEcCtD
Amobarbital—Hypotension—Doxorubicin—bone cancer	0.00455	0.00551	CcSEcCtD
Amobarbital—Constipation—Epirubicin—bone cancer	0.0045	0.00545	CcSEcCtD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—FEV—bone cancer	0.00448	0.0467	CbGpPWpGaD
Amobarbital—Body temperature increased—Methotrexate—bone cancer	0.00445	0.00538	CcSEcCtD
Amobarbital—Feeling abnormal—Epirubicin—bone cancer	0.00434	0.00525	CcSEcCtD
Amobarbital—Somnolence—Doxorubicin—bone cancer	0.00433	0.00524	CcSEcCtD
Amobarbital—Constipation—Doxorubicin—bone cancer	0.00417	0.00504	CcSEcCtD
Amobarbital—Body temperature increased—Epirubicin—bone cancer	0.00416	0.00503	CcSEcCtD
Amobarbital—Hypersensitivity—Methotrexate—bone cancer	0.00415	0.00501	CcSEcCtD
Amobarbital—Feeling abnormal—Doxorubicin—bone cancer	0.00402	0.00486	CcSEcCtD
Amobarbital—Hypersensitivity—Epirubicin—bone cancer	0.00388	0.00469	CcSEcCtD
Amobarbital—Body temperature increased—Doxorubicin—bone cancer	0.00385	0.00466	CcSEcCtD
Amobarbital—Dizziness—Methotrexate—bone cancer	0.00372	0.0045	CcSEcCtD
Amobarbital—Hypersensitivity—Doxorubicin—bone cancer	0.00359	0.00434	CcSEcCtD
Amobarbital—Vomiting—Methotrexate—bone cancer	0.00358	0.00433	CcSEcCtD
Amobarbital—Rash—Methotrexate—bone cancer	0.00355	0.00429	CcSEcCtD
Amobarbital—Dermatitis—Methotrexate—bone cancer	0.00354	0.00429	CcSEcCtD
Amobarbital—Headache—Methotrexate—bone cancer	0.00353	0.00426	CcSEcCtD
Amobarbital—Dizziness—Epirubicin—bone cancer	0.00348	0.00421	CcSEcCtD
Amobarbital—Vomiting—Epirubicin—bone cancer	0.00335	0.00405	CcSEcCtD
Amobarbital—Nausea—Methotrexate—bone cancer	0.00334	0.00404	CcSEcCtD
Amobarbital—Rash—Epirubicin—bone cancer	0.00332	0.00402	CcSEcCtD
Amobarbital—Dermatitis—Epirubicin—bone cancer	0.00332	0.00401	CcSEcCtD
Amobarbital—Headache—Epirubicin—bone cancer	0.0033	0.00399	CcSEcCtD
Amobarbital—Dizziness—Doxorubicin—bone cancer	0.00322	0.0039	CcSEcCtD
Amobarbital—Nausea—Epirubicin—bone cancer	0.00313	0.00378	CcSEcCtD
Amobarbital—Vomiting—Doxorubicin—bone cancer	0.0031	0.00375	CcSEcCtD
Amobarbital—Rash—Doxorubicin—bone cancer	0.00307	0.00372	CcSEcCtD
Amobarbital—Dermatitis—Doxorubicin—bone cancer	0.00307	0.00371	CcSEcCtD
Amobarbital—Headache—Doxorubicin—bone cancer	0.00305	0.00369	CcSEcCtD
Amobarbital—Nausea—Doxorubicin—bone cancer	0.00289	0.0035	CcSEcCtD
Amobarbital—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00286	0.0298	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00278	0.0289	CbGpPWpGaD
Amobarbital—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.00239	0.0249	CbGpPWpGaD
Amobarbital—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.0023	0.024	CbGpPWpGaD
Amobarbital—GABRA6—Orphan transporters—TUBB4B—bone cancer	0.00221	0.023	CbGpPWpGaD
Amobarbital—GABRA4—Orphan transporters—TUBB4B—bone cancer	0.00218	0.0227	CbGpPWpGaD
Amobarbital—GABRA5—Orphan transporters—TUBB4B—bone cancer	0.00194	0.0202	CbGpPWpGaD
Amobarbital—GABRA6—Orphan transporters—TUBB2A—bone cancer	0.00191	0.0199	CbGpPWpGaD
Amobarbital—GABRA3—Orphan transporters—TUBB4B—bone cancer	0.0019	0.0198	CbGpPWpGaD
Amobarbital—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.00189	0.0197	CbGpPWpGaD
Amobarbital—GABRA4—Orphan transporters—TUBB2A—bone cancer	0.00188	0.0196	CbGpPWpGaD
Amobarbital—GABRA2—Orphan transporters—TUBB4B—bone cancer	0.00187	0.0195	CbGpPWpGaD
Amobarbital—GABRA5—Orphan transporters—TUBB2A—bone cancer	0.00167	0.0174	CbGpPWpGaD
Amobarbital—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00164	0.0171	CbGpPWpGaD
Amobarbital—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.00164	0.0171	CbGpPWpGaD
Amobarbital—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.00161	0.0168	CbGpPWpGaD
Amobarbital—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.00159	0.0166	CbGpPWpGaD
Amobarbital—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—bone cancer	0.00157	0.0164	CbGpPWpGaD
Amobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—bone cancer	0.00146	0.0152	CbGpPWpGaD
Amobarbital—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.00138	0.0143	CbGpPWpGaD
Amobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.00127	0.0132	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—EIF2S1—bone cancer	0.00123	0.0128	CbGpPWpGaD
Amobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.00114	0.0119	CbGpPWpGaD
Amobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000994	0.0103	CbGpPWpGaD
Amobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000981	0.0102	CbGpPWpGaD
Amobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000806	0.00839	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000715	0.00745	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000651	0.00678	CbGpPWpGaD
Amobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000599	0.00624	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000547	0.0057	CbGpPWpGaD
Amobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000545	0.00568	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000539	0.00562	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000538	0.0056	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000532	0.00554	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00053	0.00552	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—BRAF—bone cancer	0.000489	0.00509	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000473	0.00493	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000465	0.00485	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000464	0.00484	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00046	0.00479	CbGpPWpGaD
Amobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000458	0.00477	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000456	0.00475	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000455	0.00474	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—MDM2—bone cancer	0.00045	0.00469	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000449	0.00468	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000444	0.00463	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—JUN—bone cancer	0.000434	0.00453	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000428	0.00446	CbGpPWpGaD
Amobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000423	0.0044	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000417	0.00435	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000417	0.00435	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—BRAF—bone cancer	0.000412	0.00429	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000411	0.00428	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—MDM2—bone cancer	0.00041	0.00427	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000408	0.00425	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000401	0.00418	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000399	0.00416	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—BRAF—bone cancer	0.000399	0.00415	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000394	0.0041	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000392	0.00408	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—JUN—bone cancer	0.000389	0.00406	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000389	0.00405	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000385	0.00401	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000381	0.00397	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000376	0.00392	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—BRAF—bone cancer	0.000375	0.0039	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000366	0.00381	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—bone cancer	0.000354	0.00369	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—MDM2—bone cancer	0.000345	0.00359	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000344	0.00359	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—BRAF—bone cancer	0.000342	0.00356	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—BRAF—bone cancer	0.000338	0.00352	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000336	0.0035	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000334	0.00348	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—bone cancer	0.000334	0.00348	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000328	0.00342	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000328	0.00342	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000323	0.00336	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—BRAF—bone cancer	0.000315	0.00328	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—MDM2—bone cancer	0.000314	0.00327	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—BRAF—bone cancer	0.000305	0.00318	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—BRAF—bone cancer	0.0003	0.00312	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000295	0.00307	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000289	0.00302	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—MDM2—bone cancer	0.000286	0.00298	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—MDM2—bone cancer	0.000283	0.00295	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000275	0.00287	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—MDM2—bone cancer	0.000264	0.00275	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—BRAF—bone cancer	0.000262	0.00273	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—BRAF—bone cancer	0.000259	0.00269	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000256	0.00267	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—MDM2—bone cancer	0.000256	0.00267	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—MDM2—bone cancer	0.000251	0.00262	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000247	0.00257	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000247	0.00257	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000243	0.00253	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—BRAF—bone cancer	0.00023	0.00239	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—BRAF—bone cancer	0.000226	0.00235	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—BRAF—bone cancer	0.000222	0.00231	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—MDM2—bone cancer	0.000219	0.00229	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	0.000219	0.00228	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—MDM2—bone cancer	0.000217	0.00226	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NT5C3A—bone cancer	0.000213	0.00221	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000207	0.00215	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—MDM2—bone cancer	0.000193	0.00201	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—BRAF—bone cancer	0.000189	0.00197	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—MDM2—bone cancer	0.000189	0.00197	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—MDM2—bone cancer	0.000186	0.00194	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—MDM2—bone cancer	0.000158	0.00165	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ENO2—bone cancer	9.31e-05	0.00097	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—DHFR—bone cancer	8.64e-05	0.0009	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GNA11—bone cancer	8.07e-05	0.000841	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP3A4—bone cancer	7.32e-05	0.000762	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTP1—bone cancer	6.26e-05	0.000652	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PTGS2—bone cancer	3.24e-05	0.000338	CbGpPWpGaD
